drugset / Trial / NCT00042783

Vaccine Therapy in Treating Patients With Stage IV Melanoma

NCT00042783 ↗

Open-labelTreatment

Summary

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. Vaccine therapy may be effective in treating stage IV melanoma. PURPOSE: Phase II trial to study the effectiveness of vaccine therapy in treating patients who have stage IV melanoma.

Timeline

Start
2002-09
Primary completion
—
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject D1/3-MAGE3-HIS Unknown — Intramuscular
Background SB-AS02B Unknown — Intramuscular

Indications